Therapy efficacy post-venetoclax failure in relapesed/refractory chronic lymphocytic leukemia. https://t.co/n58vPA6Swy pic.twitter.com/npODVfsNew

— Clinical Cancer Research (@CCR_AACR) July 30, 2020

“No one wants to have to make a choice like this. Whatever you decide, you have to own it.” Two families weigh their surgical options after a diagnosis of bone cancer. https://t.co/bC0eeUERzv pic.twitter.com/aw4FnYxq7N

— Dana-Farber/Boston Children's (@DFBC_PedCare) July 31, 2020

Get a Move On: Adults over 45 years old who had greater total sedentary time had a 45%-52% greater relative risk of cancer mortality compared to their more active counterparts, according to a study from @JAMAOnc pic.twitter.com/xk7pwBE4kT

— ASH Clinical News (@ASHClinicalNews) July 31, 2020

A large international study led by MSK researchers including @PapaemmanuilLab is the first to show the impact that TP53 gene mutations have on severity and outcomes in myelodyplastic syndrome (MDS), a precursor to acute myeloid #leukemia @NatureMedicine https://t.co/XRAd33jBmw

— Memorial Sloan Kettering Cancer Center (@sloan_kettering) August 3, 2020

It’s official: #ASH20 will be held as a virtual meeting! While we will miss seeing all of you in person in San Diego, we are excited to reimagine our meeting on an innovative digital platform. Registration reopens 8/31; abstracts now due 8/10 https://t.co/35kF8OQYRc pic.twitter.com/QMLXHBhOhO

— ASH (@ASH_hematology) August 3, 2020